Story · Medicine & Biotech

Kefah Mokbel: Can Dato-DXd Overcome Treatment Resistance?

1 outlet · first reported by OncoDaily 2d ago

Coverage, in order

  1. 2d ago
    OncoDaily obscure observational
    Kefah Mokbel: Can Dato-DXd Overcome Treatment Resistance?

    Kefah Mokbel, Professor of Medicine at Cardiff University School of Medicine, shared on LinkedIn: “In this cohort of heavily pretreated HR+/HER2− metastatic or recurrent breast cancer, Dato‐DXd showed limited clinical

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.